Customer Center
Login | Register


Our xTAG® and MultiCode®-RTx Technologies serve a wide range of clinical applications, including infectious disease testing, providing exceptional sensitivity and specificity, unmatched throughput flexibility, and increased assay speed.

Read More

Research & Applied Markets

Our xMAP® Technology and its flexible, open-architecture design is used in a wide variety of applications, from academic and clinical research to biodefense and clinical diagnostics.

Read More


Become a Partner

Our Business Development team invites you to contact them to explore your potential development and commercialization applications using our xMAP® Technology. Click here to start the conversation now.

Learn More


Luminex® Blog

An Expert’s Guide to Multiplexing Immunoassays

Andrew Hudacek is a power user of our xMAP® Technology for designing multiplex immunoassays. As the Custom Luminex Assay Supervisor at Bio-Techne®, he provides valuable expertise in assay design and validation to customers in pharma and biotech organizations.

Continue Reading >

Galapagos, A Luminex Partner

Galapagos, A Luminex Partner


The team from Galapagos NV talks about their Mission to become the largest Biotech company in Europe, and how automating the Luminex FLEXMAP 3D® system is helping with their drug discovery.

Watch more videos >

Luminex on Twitter

RT @CDCFlu: #Flu is serious and can be especially dangerous for people at high risk for flu-related complications, such as young children.…
h J R
RT @CDCFlu: #FluFactFriday: Did you know? Over the past 15 flu seasons, this is the 1st time all states in the entire continental U.S. have…
h J R
RT @CDCgov: Here are steps to take if you or a loved one becomes sick with #flu. #fightflu
h J R

Latest News

January 7
Luminex Announces Preliminary Revenue for the Fourth Quarter and Full Year 2017

December 13
Luminex Corporation Declares Fourth Quarter Cash Dividend

November 14
Luminex Corporation To Present At The 29th Annual Piper Jaffray Healthcare Conference

October 31
Luminex Corporation Receives FDA Clearance for ARIES Group A Strep Assay

October 30
Luminex Corporation Reports Third Quarter 2017 Financial Results

October 9
Luminex Corporation Third Quarter Earnings Release Scheduled for October 30, 2017


Middle Tennessee Antimicrobial Stewardship Symposium
January 26
Memphis, TN

First Coast ID/CM Symposium
February 2-3
Palm Coast, FL

ASM Biothreats
February 12-43
Baltimore, MD

Northern California Branch of the American Society for Microbiology (NCASM) Spring Meeting
March 2-3
Pleasonton, CA

FAH Public Policy Conference & Business Expo
March 4-6
Washington D.C.